David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
PUT
Transocean
RIG
$6.41B
| $366K | ﹤0.01% |
40,000
-578,400
| -94% | -$5.75M |
|
|
CBI
2902
PUT
DELISTED
Chicago Bridge & Iron Nv
CBI
| $366K | ﹤0.01% |
10,000
-197,600
| -95% | -$7.07M |
|
2903
MasterCraft Boat Holdings
MCFT
$599M
| $365K | ﹤0.01% |
25,909
+9,542
| +58% | +$121K |
|
|
SCNB
2904
DELISTED
Suffolk Bancorp
SCNB
| $364K | ﹤0.01% |
14,413
+817
| +6% | +$20.8K |
|
2905
CALL
Cummins
CMI
$78.8B
| $363K | ﹤0.01% |
3,300
-42,400
| -93% | -$4.1M |
|
|
JOYY
2906
JOYY Inc
JOYY
$3.77B
| $363K | ﹤0.01% |
+5,897
| New | +$332K |
|
|
IIP
2907
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
| $363K | ﹤0.01% |
133,089
+37,717
| +40% | +$103K |
|
|
STR
2908
DELISTED
QUESTAR CORP
STR
| $361K | ﹤0.01% |
14,565
-55,840
| -79% | -$1.29M |
|
|
AGEN
2909
Agenus
AGEN
$376M
| $359K | ﹤0.01% |
+4,403
| New | +$297K |
|
2910
CALL
TripAdvisor
TRIP
$1.19B
| $359K | ﹤0.01% |
5,400
-62,900
| -92% | -$4.16M |
|
|
TRR
2911
DELISTED
Trc Companies
TRR
| $359K | ﹤0.01% |
49,514
+13,757
| +38% | +$103K |
|
|
SGM
2912
DELISTED
Stonegate Mortgage Corporation
SGM
| $359K | ﹤0.01% |
62,581
+11,003
| +21% | +$49.1K |
|
2913
Hercules Capital
HTGC
$3.27B
| $358K | ﹤0.01% |
29,772
+19,200
| +182% | +$213K |
|
|
P
2914
CALL
DELISTED
Pandora Media Inc
P
| $358K | ﹤0.01% |
40,000
-65,000
| -62% | -$638K |
|
2915
Moelis & Co
MC
$4.96B
| $357K | ﹤0.01% |
12,661
-6,310
| -33% | -$162K |
|
2916
CALL
3D Systems Corp
DDD
$518M
| $356K | ﹤0.01% |
23,000
-211,800
| -90% | -$2.18M |
|
|
EXXI
2917
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $356K | ﹤0.01% |
571,189
+505,177
| +765% | +$348K |
|
2918
Pegasystems
PEGA
$5.57B
| $355K | ﹤0.01% |
27,972
-210,644
| -88% | -$2.53M |
|
2919
B&G Foods
BGS
$277M
| $354K | ﹤0.01% |
+10,170
| New | +$359K |
|
|
GEN
2920
DELISTED
Genesis Healthcare, Inc.
GEN
| $354K | ﹤0.01% |
152,797
-37,828
| -20% | -$85.6K |
|
2921
Corcept Therapeutics
CORT
$13.3B
| $353K | ﹤0.01% |
75,511
-165,198
| -69% | -$644K |
|
2922
CALL
HF Sinclair
DINO
$16.9B
| $353K | ﹤0.01% |
10,000
-68,300
| -87% | -$2.35M |
|
|
EARN
2923
Ellington Residential Mortgage REIT
EARN
$166M
| $353K | ﹤0.01% |
29,471
-4,136
| -12% | -$48.3K |
|
2924
BlackRock TCP Capital
TCPC
$344M
| $353K | ﹤0.01% |
+23,690
| New | +$324K |
|
|
AVID
2925
DELISTED
Avid Technology Inc
AVID
| $353K | ﹤0.01% |
52,165
+27,449
| +111% | +$195K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.